Insulin and Weight Gain
Insulin therapy can cause weight gain, but modern approaches can help minimise it while controlling blood sugar.
DPP-4 Inhibitors and Weight Management
DPP-4 inhibitors are diabetes medications that are generally weight-neutral, making them a useful option for some patients.
Bimagrumab
An investigational medication being studied for obesity that helps people lose fat while preserving muscle.
Oral Semaglutide (Rybelsus)
Oral semaglutide (Rybelsus) is a once-daily tablet GLP-1 medication that curbs appetite and helps with weight and blood-sugar control.
Lixisenatide
A short-acting injectable GLP-1 medicine for type 2 diabetes with modest weight-loss benefits.
Danuglipron
An investigational oral GLP-1 weight-loss tablet in clinical trials, and how it may expand treatment options.
Phentermine-Topiramate (Qsymia)
A prescription combination of phentermine and topiramate that curbs appetite and reduces weight by about 8 to 10 percent at one year.
Amycretin
An investigational oral GLP-1 and amylin co-agonist in trials that has shown substantial early weight loss.
Sibutramine
A satiety-enhancing weight-loss drug withdrawn in 2010 due to increased heart and stroke risk.
Oxyntomodulin
A gut hormone that reduces appetite and is being developed as a new injectable treatment for obesity.